DexCare Acquires Mila Health, Expanding AI in Healthcare

What happened

DexCare, a prominent digital health access platform, has announced its acquisition of Mila Health. This strategic move aims to integrate Mila Health's AI-powered care coordination capabilities into DexCare's existing platform, which currently leverages AI for patient scheduling and engagement. The acquisition is set to expand DexCare's offering, enabling a more comprehensive patient journey from initial access through to ongoing care management, utilising AI agents across these critical touchpoints.

Why it matters

This acquisition highlights a growing trend in the healthcare sector towards consolidating AI-driven solutions to enhance operational efficiency and patient experience. For AI governance and ethics, the integration of AI agents across a broader spectrum of patient interactions—from scheduling to care coordination—underscores the increasing need for robust ethical frameworks. Ensuring transparency in AI decision-making, maintaining data privacy, and preventing algorithmic bias become even more critical as AI systems assume greater roles in sensitive healthcare processes. Business leaders in AI must consider the implications of such expanded AI use on patient trust and regulatory compliance.

The Institute take

While often framed as a technological advancement, this acquisition represents a significant step towards the deeper embedding of AI agents within the sensitive domain of patient care, moving beyond mere administrative tasks.

The true challenge for responsible AI leaders here lies not just in the technical integration, but in proactively addressing the ethical complexities of AI agents influencing patient pathways. It is imperative to establish clear protocols for human oversight, ensure explainability of AI recommendations, and rigorously test for equitable outcomes to prevent exacerbating existing healthcare disparities, rather than merely optimising for efficiency.